Dallas Area Habitat for Humanity
Grant in 2024
Dallas Area Habitat for Humanity builds homes for families and community partners.
PlantSwitch
Convertible Note in 2024
PlantSwitch develops compostable bioplastic resins from renewable plant-based materials and agricultural waste streams. It uses proprietary cellulose-based technology to lower biopolymer costs by up to 40% while enhancing sustainability, accessibility and mechanical properties. The resins are derived from renewable resources such as cornstarch and sugarcane and are engineered to degrade more quickly and safely in the environment than conventional plastics. PlantSwitch aims to replace single-use plastics with practical, eco-friendly alternatives and is advancing toward commercialization with its first production facility.
PlantSwitch
Seed Round in 2023
PlantSwitch develops compostable bioplastic resins from renewable plant-based materials and agricultural waste streams. It uses proprietary cellulose-based technology to lower biopolymer costs by up to 40% while enhancing sustainability, accessibility and mechanical properties. The resins are derived from renewable resources such as cornstarch and sugarcane and are engineered to degrade more quickly and safely in the environment than conventional plastics. PlantSwitch aims to replace single-use plastics with practical, eco-friendly alternatives and is advancing toward commercialization with its first production facility.
Apnimed, Inc. is a clinical-stage company based in Cambridge, Massachusetts, focused on developing innovative pharmacologic therapies for sleep apnea and related disorders. Founded in 2017, Apnimed aims to address the underlying neurobiological mechanisms that contribute to obstructive sleep apnea (OSA), a serious condition affecting over 20 million Americans. Current treatment options primarily involve positive pressure devices, which can be cumbersome, while Apnimed's approach seeks to provide a simpler, safe, and effective orally dosed medication. The company's therapeutics target both the physiological and symptomatic effects of OSA, with the goal of improving daily functioning and reducing the significant morbidity and mortality associated with this disorder.
Jernigan Capital
Acquisition in 2020
Jernigan Capital, Inc. is a commercial real estate finance company that specializes in providing capital to private developers, owners, and operators of self-storage facilities. The company aims to deliver long-term returns by investing in newly constructed self-storage properties and offering loans secured by operating self-storage facilities. Jernigan Capital focuses on generating revenue primarily through interest income from these investments, which include construction loans and operating property loans. The company has a diverse portfolio, with development investments located in cities such as Orlando, Atlanta, Tampa, Chicago, and Miami, while its operating property loans are situated in New Orleans, Newark, Nashville, Sacramento, and Chicago. Jernigan Capital conducts its investment activities through its subsidiary, Jernigan Capital Operating Company, LLC, and is externally managed and advised by JCap Advisors, LLC.
VineBrook Homes
Private Equity Round in 2019
VineBrook Homes is a real estate company established in 2007, focusing on acquiring, renovating, and leasing single-family homes. Unlike other providers, VineBrook prioritizes affordability and value for its residents, making it one of the largest suppliers of quality rental homes with diverse housing options. The company's dedicated staff, guided by core values of hard work, integrity, communication, and execution, strives to deliver exceptional experiences to current and future residents while being a responsible community citizen.